| Ytd | 59.85% | |
| 1y | 62.10% |
| Open | 395.67 | Prev Close | 397.22 | Low | 391.96 | High | 414.82 | Mkt Cap | 49.16B |
| Vol | 1.46M | Avg Vol | 1.71M | EPS | 9.38 | P/E | 43.65 | Forward P/E | 26.01 |
| Beta | 0.77 | Short Ratio | 4.88 | Inst. Own | 99.88% | Dividend | 3.54 | Div Yield | 0.89 |
| Ex Div Date | 06-26 | Earning | 07-29 | 50-d Avg | 310.60 | 200-d Avg | 252.40 | 1yr Est | 304.33 |
Medicare GLP-1 coverage starts Wednesday. Here’s what patients should know about cost, eligibility a
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE:
O'Reilly's extensive experience across healthcare compliance, risk management, regulatory oversight
CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions,
Swedish care provider Ambea said on Monday it had made a recommended public offer for peer Humana ,
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
B of A Securities analyst Kevin Fischbeck maintains Humana (NYSE:HUM) with a Neutral and raises t
Evercore ISI Group analyst Elizabeth Suzuki maintains Humana (NYSE:HUM) with a In-Line and raises
Federal investigators found Medicare Advantage plans frequently denied requests for nursing and reha
Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium
Mizuho analyst Ann Hynes maintains Humana (NYSE:HUM) with a Outperform and raises the price targe
JP Morgan analyst Lisa Gill maintains Humana (NYSE:HUM) with a Neutral and raises the price targe
B of A Securities analyst Kevin Fischbeck maintains Humana (NYSE:HUM) with a Neutral and raises t
Morgan Stanley analyst Erin Wright maintains Humana (NYSE:HUM) with a Underweight and raises the
Truist Securities analyst David Macdonald maintains Humana (NYSE:HUM) with a Hold and raises the
Mizuho analyst Ann Hynes maintains Humana (NYSE:HUM) with a Outperform and raises the price targe
Deutsche Bank analyst George Hill upgrades Humana (NYSE:HUM) from Hold to Buy and raises the pric
Morgan Stanley analyst Erin Wright maintains Humana (NYSE:HUM) with a Underweight and raises the
https://www.cms.gov/newsroom/press-releases/cms-announces-aggressive-nationwide-crackdown-fraud-six-
ZBRA, VSTS, AMBQ, VPG, BAK, PACS, LOT, EIKN, DDD, WEN, SIBN post significant gains on better-than-ex
TD Cowen analyst Ryan Langston maintains Humana (NYSE:HUM) with a Hold and raises the price targe
JP Morgan analyst Lisa Gill maintains Humana (NYSE:HUM) with a Neutral and raises the price targe
RBC Capital analyst Ben Hendrix maintains Humana (NYSE:HUM) with a Sector Perform and raises the
Guggenheim analyst Jason Cassorla maintains Humana (NYSE:HUM) with a Buy and raises the price tar
Barclays analyst Andrew Mok maintains Humana (NYSE:HUM) with a Equal-Weight and raises the price
Evercore ISI Group analyst Elizabeth Suzuki maintains Humana (NYSE:HUM) with a In-Line and raises
Truist Securities analyst David Macdonald maintains Humana (NYSE:HUM) with a Hold and raises the
Humana stock rises after Q1 earnings beat; revenue jumps, membership surges despite profit dip and o
Humana (NYSE:HUM) FY2026 expected to be more than $9.00 vs $8.72 Est. FY2026 Revenue expected to b
Humana (NYSE:HUM) reported quarterly earnings of $10.31 per share which beat the analyst consensus e
Humana (NYSE:HUM) reported quarterly earnings of $10.31 per share which beat the analyst consensus e
Truist Securities analyst David Macdonald maintains Humana (NYSE:HUM) with a Hold and raises the
The Donald Trump administration conceded it used the wrong numbers to help launch a Medicaid fraud i
Medicare's news of a 2.48% payment rate increase for health insurers in 2027 has sparked a rally
Oil prices keep investors on the defensive. U.S. equities fell as WTI crude topped $115 on Trump'
A Medicare policy boost sends UnitedHealth stock and Humana higher, with ETFs emerging as key benefi
Medicare Advantage stocks surge as CMS finalizes 2027 rates. Read about the 2.48% base rate hike and
Dow Jones falls 250 points as UnitedHealth Group rises on Medicare reimbursement boost, other stocks
SILO stock rose 51.8% in pre-market trading after its PTSD treatment pipeline received a patent from
https://www.cms.gov/newsroom/press-releases/cms-finalizes-2027-medicare-advantage-part-d-payment-pol
Mark Cuban, billionaire entrepreneur and CEO of Costplusdrugs.com, praised TrumpRx, a prescription d